New Products

Premium

Clontech Laboratories has released its SMARTer Ultra Low RNA Kit for sequencing on Illumina platforms. The kit, developed in collaboration with Illumina, incorporates a modified version of Clontech's SMART,technology, which stands for switching mechanism at 5' end of RNA template. According to Clontech, the kit enables researchers to perform an entire sample-prep protocol with as little as 100 picograms of input RNA and in a single tube without a separate adapter-ligation step.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.